The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Name

7 Oct 2022 07:00

RNS Number : 0953C
Honeycomb Investment Trust PLC
07 October 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

THIS IS AN ANNOUNCEMENT AND NOT A PROSPECTUS OR EQUIVALENT DOCUMENT. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM PART OF, AND SHOULD NOT BE CONSTRUED AS, ANY OFFER, INVITATION OR RECOMMENDATION TO PURCHASE, SELL OR SUBSCRIBE FOR ANY SECURITIES IN ANY JURISDICTION AND NEITHER THE ISSUE OF THE INFORMATION NOR ANYTHING CONTAINED HEREIN SHALL FORM THE BASIS OF OR BE RELIED UPON IN CONNECTION WITH, OR ACT AS AN INDUCEMENT TO ENTER INTO, ANY INVESTMENT ACTIVITY

 

FOR IMMEDIATE RELEASE

7 October 2022

Honeycomb Investment Trust plc ("Honeycomb")

Change of Name

Honeycomb announces, following the completion of the all share combination between Honeycomb and Pollen Street Capital Holdings Limited, that it has changed its name to Pollen Street plc. The change of name, which took effect yesterday, 6 October 2022, has been approved by the Board of Directors in accordance with Honeycomb's Articles of Association. Honeycomb's shares will trade under the new name on the London Stock Exchange from 8.00 a.m. London time on 10 October 2022. The Company's trading instrument display mnemonic ("TIDM") will also change from HONY to POLN with effect from 8.00 a.m. London time on 10 October 2022. The ISIN and SEDOL numbers will remain unchanged. As of today, the Company's website address has been amended to https://www.pollenstreetgroup.com/.

Enquiries:

Cenkos - Financial Adviser, Sponsor and Joint Broker to Honeycomb

Tunga Chigovanyika

Daniel BalabanoffJustin Zawoda Martin

+44 20 7397 8900

 

BofA Securities - Financial Adviser to Honeycomb Geoff Iles

Oliver Elias

Charles Pitt Ford

+44 20 7628 1000

Liberum - Joint Broker

Chris Clarke

+44 20 3100 2000

 

Barclays Bank PLC - Joint Broker Neal WestDion Di MiceliChris MaddersonStuart Muress+44 (0) 20 7623 2323

FGS Global - Communications Adviser

Chris Sibbald

+44 20 7251 3801

 

About Honeycomb

Honeycomb is a UK-listed closed ended investment trust dedicated to providing investors with access to asset backed lending opportunities, with potential to generate high income returns, together with strong capital preservation.

About Pollen Street

Pollen Street was founded in 2013 and is an independent, alternative investment management company dedicated to investing in the financial and business services sectors. Pollen Street has extensive experience investing in both credit and private equity strategies and has a strong and consistent track record of delivering top tier returns. A wholly owned subsidiary of Pollen Street serves as Honeycomb's investment manager.

Additional information

Merrill Lynch International ("BofA Securities"), which is authorised by the Prudential Regulation Authority ("PRA") and regulated by the FCA and the PRA in the United Kingdom, is acting as financial adviser exclusively for Honeycomb and for no one else and will not be responsible to anyone other than Honeycomb for providing the protections afforded to its clients or for providing advice in relation to the matters referred to in this announcement. Neither BofA Securities, nor any of its affiliates, owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of BofA Securities in connection with this announcement, the Prospectus, or any statement contained herein or otherwise.

Cenkos Securities plc ("Cenkos"), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively as financial adviser and sponsor for Honeycomb and for no one else in connection with the Combination and Admission and will not be responsible to anyone other than Honeycomb for providing the protections afforded to its clients or for providing advice in relation to the matters referred to in this announcement or any other arrangement referred to, or information contained in, the Prospectus. Neither Cenkos, nor any of its affiliates, owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Cenkos in connection with this announcement, the Prospectus, or any statement contained herein or otherwise.

Liberum Capital Limited ("Liberum") is authorised and regulated in the United Kingdom by the FCA and is acting exclusively for Honeycomb and no-one else in connection with the proposed Combination and will not be responsible to anyone other than the Honeycomb for providing the protections afforded to the clients of Liberum, as applicable, or for affording advice in relation to the contents of the announcement, the Prospectus, or any matters referred to therein. Nothing in this paragraph shall serve to exclude or limit any responsibilities Liberum may have under the Financial Services and Markets Act 2000 or the regulatory regime established thereunder.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CANFSDESMEESESS
Date   Source Headline
12th Aug 20202:11 pmRNSForm 8.3 - [Honeycomb Investment Trust Plc]
12th Aug 20201:30 pmRNSForm 8.3 - Honeycomb Investment Trust Plc
12th Aug 20209:09 amRNSForm 8.5 (EPT/RI)
11th Aug 202011:51 amGNWForm 8 (OPD) [Honeycomb Investment Trust plc] - (HHL)
11th Aug 20209:56 amRNSForm 8.5 (EPT/RI)
10th Aug 20202:50 pmRNSForm 8.5 (EPT/RI)
10th Aug 20202:23 pmRNSShare Buy-Back Programme
10th Aug 20201:09 pmRNSForm 8.3 - Honeycomb Investment Trust PLC
10th Aug 202012:51 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Honeycomb Investment Trust plc
10th Aug 20209:57 amRNSForm 8.5 (EPT/RI)
7th Aug 20201:36 pmRNSForm 8.3 - Honeycomb Investment Trust plc
6th Aug 20206:24 pmRNSPossible offer for Pollen Street Secured Lending
3rd Aug 20207:01 amRNSMonthly Update - June 2020
3rd Aug 20207:00 amRNSNet Asset Value(s)
26th Jun 20205:41 pmRNSResult of AGM
25th Jun 20207:01 amRNSMonthly Update - May 2020
25th Jun 20207:00 amRNSNet Asset Value(s)
4th Jun 20201:41 pmRNSDirector/PDMR Shareholding
4th Jun 202011:21 amRNSHolding(s) in Company
3rd Jun 20204:39 pmRNSPosting of Annual Report and Notice of AGM
3rd Jun 20207:00 amRNSResult of Buyback and Total Voting Rights
2nd Jun 20204:30 pmRNSShare Buy-Back
28th May 20207:01 amRNSMonthly Update - April 2020
28th May 20207:00 amRNSNet Asset Value(s)
28th May 20207:00 amRNSDividend Declaration
28th May 20207:00 amRNSAnnual Report and Audited Financial Statements
4th May 20201:06 pmRNSDirector/PDMR Shareholding
1st May 20207:01 amRNSMonthly Update - March 2020
1st May 20207:00 amRNSNet Asset Value(s)
26th Mar 20207:01 amRNSMonthly Update - February 2020
26th Mar 20207:00 amRNSNet Asset Value(s)
5th Mar 20205:08 pmRNSHolding(s) in Company
5th Mar 20204:34 pmRNSHolding(s) in Company
2nd Mar 20209:12 amRNSRelationship with Pollen Street Capital
2nd Mar 20207:01 amRNSMonthly Update - January 2020
2nd Mar 20207:00 amRNSNet Asset Value(s)
25th Feb 202012:02 pmRNSHolding(s) in Company
25th Feb 202010:31 amRNSHolding(s) in Company
24th Feb 20201:15 pmRNSHolding(s) in Company
24th Feb 202011:31 amRNSHolding(s) in Company
21st Feb 20204:38 pmRNSResult of Share Sale
21st Feb 20204:31 pmRNSHolding(s) in Company
21st Feb 20202:32 pmRNSProposed Share Sale
19th Feb 20203:15 pmRNSHolding(s) in Company
19th Feb 20207:00 amRNSDividend Declaration
31st Jan 202010:02 amRNSHolding(s) in Company
30th Jan 202012:30 pmRNSHolding(s) in Company
29th Jan 20202:27 pmRNSHolding(s) in Company
29th Jan 20202:10 pmRNSHolding(s) in Company
28th Jan 20205:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.